Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Cleary

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Best Practice & Research. Clinical Haematology|December 5, 2009
Regulating the leukaemia stem cellMichael L Cleary
Blood|March 18, 2009
Therapeutic targeting of MLLMichaela Liedtke, Michael L Cleary
Nature|January 20, 2012
Genomics: The path to retinoblastomaJulien Sage, Michael L Cleary
Cancer Cell|July 5, 2008
Menin critically links MLL proteins with LEDGF on cancer-associated target genesAkihiko Yokoyama, Michael L Cleary
Blood|October 24, 2002
Common mechanism for oncogenic activation of MLL by forkhead family proteinsChi Wai So, Michael L Cleary
Molecular and Cellular Biology|August 23, 2002
MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein functionChi Wai So, Michael L Cleary
Cancer Cell|March 22, 2014
The AML salad bowlJesús Duque-Afonso, Michael L Cleary
Genes & Development|September 4, 2003
Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9Paul M Ayton, Michael L Cleary
Expert Opinion on Drug Discovery|September 13, 2014
Novel methods and approaches to acute lymphoblastic leukemia drug discoveryMichael C Wei, Michael L Cleary
Blood|May 8, 2004
Dimerization: a versatile switch for oncogenesisChi Wai So, Michael L Cleary
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Best Practice & Research. Clinical Haematology|December 5, 2009
Regulating the leukaemia stem cellMichael L Cleary
Blood|March 18, 2009
Therapeutic targeting of MLLMichaela Liedtke, Michael L Cleary
Nature|January 20, 2012
Genomics: The path to retinoblastomaJulien Sage, Michael L Cleary
Cancer Cell|July 5, 2008
Menin critically links MLL proteins with LEDGF on cancer-associated target genesAkihiko Yokoyama, Michael L Cleary
Blood|October 24, 2002
Common mechanism for oncogenic activation of MLL by forkhead family proteinsChi Wai So, Michael L Cleary
Molecular and Cellular Biology|August 23, 2002
MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein functionChi Wai So, Michael L Cleary
Cancer Cell|March 22, 2014
The AML salad bowlJesús Duque-Afonso, Michael L Cleary
Genes & Development|September 4, 2003
Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9Paul M Ayton, Michael L Cleary
Expert Opinion on Drug Discovery|September 13, 2014
Novel methods and approaches to acute lymphoblastic leukemia drug discoveryMichael C Wei, Michael L Cleary
Blood|May 8, 2004
Dimerization: a versatile switch for oncogenesisChi Wai So, Michael L Cleary
Pageof 10